Drugs / Yinzhihuang Oral Liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02594904 | Jul 2015 → Apr 2016 | hyperbilirubinemia | Southern Medical University, China | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yinzhihuang Oral Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02594904 ↗ |